Impaired glucose homeostasis in obesity is mitigated by enhancing the glucoregulatory actions of glucagon-like peptide 1 (GLP-1), and thus, strategies that improve GLP-1 sensitivity and secretion have therapeutic potential for the treatment of type 2 diabetes. This study shows that Holdemanella biformis, isolated from the feces of a metabolically healthy volunteer, ameliorates hyperglycemia, improves oral glucose tolerance and restores gluconeogenesis and insulin signaling in the liver of obese mice. These effects were associated with the ability of H. biformis to restore GLP-1 levels, enhancing GLP-1 neural signaling in the proximal and distal small intestine and GLP-1 sensitivity of vagal sensory neurons, and to modify the cecal abundance of unsaturated fatty acids and the bacterial species associated with metabolic health. Our findings overall suggest the potential use of H biformis in the management of type 2 diabetes in obesity to optimize the sensitivity and function of the GLP-1 system, through direct and indirect mechanisms.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1096/fj.202100126R | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Influence of Peanut Consumption on the Gut Microbiome: A Randomized Clinical Trial.
Nutrients
September 2024
Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.
Peanut consumption could impact cardiometabolic health through gut microbiota, a hypothesis that remains to be investigated. A randomized clinical trial in Vietnam evaluated whether peanut consumption alters gut microbiome communities. : One hundred individuals were included and randomly assigned to the peanut intervention and control groups.
View Article and Find Full Text PDFSpecies-level characterization of the core microbiome in healthy dogs using full-length 16S rRNA gene sequencing.
Front Vet Sci
September 2024
AnimalBiome, Oakland, CA, United States.
Despite considerable interest and research in the canine fecal microbiome, our understanding of its species-level composition remains incomplete, as the majority of studies have only provided genus-level resolution. Here, we used full-length 16S rRNA gene sequencing to characterize the fecal microbiomes of 286 presumed healthy dogs living in homes in North America who are devoid of clinical signs, physical conditions, medication use, and behavioral problems. We identified the bacterial species comprising the core microbiome and investigated whether a dog's sex & neuter status, age, body weight, diet, and geographic region predicted microbiome variation.
View Article and Find Full Text PDFReduction of butyrate-producing bacteria in the gut microbiome of Japanese patients with pancreatic cancer.
Pancreatology
November 2024
Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
Article Synopsis
- * Researchers discovered an increase in the genus Streptococcus and a decrease in butyrate-producing bacteria in pancreatic cancer patients, which may influence cancer progression.
- * The results suggest a unique microbial signature in Japanese patients with pancreatic cancer, highlighting the need for further research to understand the microbiome's potential role in the disease and to explore targeted treatment options.
Assessment of the potential risks in SD rats gavaged with genetically modified yeast containing the gene.
Front Vet Sci
August 2024
Key Laboratory for Biobased Materials and Energy of Ministry of Education, Research Center of Biomass 3D Printing Materials, College of Materials and Energy, South China Agricultural University, Guangzhou, China.
Introduction: Despite the absence of definitive evidence indicating that the cp4-epsps gene and its resultant recombinant proteins have significant harmful effects on either human or animal health, the safety assessment of genetically modified (GM) crops expressing the CP4-EPSPS proteins has been controversial. This study endeavor was aimed at evaluating the potential risks posed by the CP4-EPSPS protein in transgenic crops, thereby contributing to the advancement of risk assessment methodologies in the context of genetically engineered crops.
Methods: To ascertain the appropriate daily dosages for oral gavage administration, the expression levels of the CP4-EPSPS protein in a recombinant yeast were quantified.
Gut microbiota from patients with Parkinson's disease causes motor deficits in honeybees.
Front Microbiol
July 2024
Microbiota Division, Department of Gastroenterology and Hepatology, First Medical Center, Chinese PLA General Hospital, Beijing, China.
Objective: Parkinson's disease (PD) is possibly caused by genetic factors, environmental factors, and gut microbiota dysbiosis. This study aims to explore whether the microbiota contributes to the behavior abnormalities of PD.
Methods: We transplanted gut microbiota from patients with PD or healthy controls (HC) into microbiota-free honeybees.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!